After achieving the pinnacle of success during the Covid vaccine era, PFE has struggled to recover from falling vaccine sales. I had considered abandoning my core holdings but on further investigation, I liked what they were doing with their cancer drugs and continued to hold. A hefty dividend, albeit not supported much by earnings, continued also to be an attraction. The current washout with the nomination of Robert Kennedy Jr for a cabinet position could have been the last. AI generated pattern finder offers tempting long term gains.